The most commonly observed adverse events (incidence of 5% and twice that of placebo) were oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence
It is because of this dual pathway that some clinicians and patients speculate that microdosing may prove effective
IGF-1 LR3 Protocol Mistakes & Troubleshooting 01 Hypoglycemic symptoms after injection Shakiness, sweating, confusion, or rapid heartbeat can indicate hypoglycemia and warrant stopping the protocol and seeking immediate medical attention
& Mitnik, O
Ann Thorac Surg 117(2):320-326, 2024
2a), which was then applied to local refinement in CryoSPARC